Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vibrio cholerae | 47 | 2024 | 98 | 8.890 |
Why?
|
Francisella tularensis | 36 | 2017 | 115 | 5.960 |
Why?
|
Bacterial Proteins | 50 | 2023 | 540 | 5.670 |
Why?
|
Gene Expression Regulation, Bacterial | 33 | 2023 | 149 | 4.410 |
Why?
|
Flagella | 13 | 2023 | 29 | 3.420 |
Why?
|
Tularemia | 28 | 2016 | 114 | 3.330 |
Why?
|
Vibrio | 8 | 2023 | 16 | 2.460 |
Why?
|
Transcription Factors | 17 | 2014 | 681 | 2.190 |
Why?
|
Virulence Factors | 12 | 2018 | 113 | 2.120 |
Why?
|
DNA-Binding Proteins | 17 | 2007 | 539 | 1.810 |
Why?
|
Cholera | 15 | 2024 | 70 | 1.780 |
Why?
|
Virulence | 33 | 2023 | 223 | 1.740 |
Why?
|
Francisella | 6 | 2016 | 19 | 1.570 |
Why?
|
Transcription, Genetic | 16 | 2011 | 578 | 1.320 |
Why?
|
Bacterial Outer Membrane Proteins | 10 | 2014 | 52 | 1.310 |
Why?
|
Bacterial Vaccines | 14 | 2016 | 125 | 1.260 |
Why?
|
Mutagenesis, Insertional | 5 | 2009 | 32 | 1.230 |
Why?
|
Flagellin | 8 | 2018 | 16 | 1.190 |
Why?
|
Cloning, Molecular | 4 | 2021 | 325 | 1.160 |
Why?
|
Macrophages | 17 | 2014 | 439 | 1.140 |
Why?
|
Mice | 51 | 2023 | 5913 | 1.120 |
Why?
|
Diatoms | 1 | 2023 | 7 | 0.930 |
Why?
|
Animals | 64 | 2024 | 15081 | 0.920 |
Why?
|
Genetic Vectors | 4 | 2021 | 158 | 0.920 |
Why?
|
Biofilms | 10 | 2019 | 168 | 0.880 |
Why?
|
Vibrio cholerae O1 | 2 | 2021 | 11 | 0.850 |
Why?
|
Molecular Sequence Data | 22 | 2014 | 1568 | 0.840 |
Why?
|
Intestines | 12 | 2023 | 64 | 0.840 |
Why?
|
Sigma Factor | 6 | 2004 | 19 | 0.840 |
Why?
|
Genomic Islands | 7 | 2009 | 14 | 0.800 |
Why?
|
Gram-Negative Bacteria | 2 | 2021 | 22 | 0.790 |
Why?
|
Transformation, Bacterial | 1 | 2021 | 12 | 0.790 |
Why?
|
DNA, Bacterial | 6 | 2009 | 186 | 0.790 |
Why?
|
Phagosomes | 8 | 2010 | 30 | 0.780 |
Why?
|
Adhesins, Bacterial | 7 | 2024 | 20 | 0.770 |
Why?
|
Lipoproteins | 2 | 2014 | 64 | 0.770 |
Why?
|
Interferon-gamma | 10 | 2016 | 250 | 0.710 |
Why?
|
Gastrointestinal Tract | 3 | 2023 | 61 | 0.700 |
Why?
|
Trans-Activators | 6 | 2007 | 174 | 0.700 |
Why?
|
DNA-Directed RNA Polymerases | 6 | 2010 | 22 | 0.700 |
Why?
|
Fimbriae Proteins | 3 | 2008 | 21 | 0.690 |
Why?
|
Vaccination | 4 | 2017 | 288 | 0.670 |
Why?
|
Mice, Inbred BALB C | 20 | 2016 | 661 | 0.660 |
Why?
|
Introns | 2 | 2009 | 75 | 0.640 |
Why?
|
Bile | 7 | 2011 | 10 | 0.640 |
Why?
|
Gene Targeting | 2 | 2008 | 38 | 0.620 |
Why?
|
Intubation, Intratracheal | 1 | 2017 | 19 | 0.610 |
Why?
|
Gram-Negative Bacterial Infections | 3 | 2016 | 22 | 0.580 |
Why?
|
Polymerase Chain Reaction | 5 | 2007 | 448 | 0.540 |
Why?
|
Cholera Toxin | 4 | 2014 | 39 | 0.540 |
Why?
|
Plasmids | 8 | 2021 | 246 | 0.520 |
Why?
|
Genes, Bacterial | 9 | 2014 | 90 | 0.520 |
Why?
|
Cyclic GMP | 3 | 2019 | 47 | 0.500 |
Why?
|
Two-Hybrid System Techniques | 2 | 2014 | 50 | 0.500 |
Why?
|
Immunodominant Epitopes | 1 | 2014 | 27 | 0.500 |
Why?
|
RNA, Bacterial | 1 | 2014 | 33 | 0.490 |
Why?
|
Vaccines, Attenuated | 9 | 2016 | 72 | 0.490 |
Why?
|
Porins | 4 | 2003 | 19 | 0.490 |
Why?
|
Base Sequence | 11 | 2014 | 997 | 0.480 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 40 | 0.470 |
Why?
|
Quality Assurance, Health Care | 1 | 2014 | 56 | 0.470 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 191 | 0.450 |
Why?
|
Quality of Health Care | 1 | 2014 | 138 | 0.450 |
Why?
|
Humans | 47 | 2024 | 37093 | 0.450 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 173 | 0.440 |
Why?
|
Promoter Regions, Genetic | 10 | 2018 | 515 | 0.420 |
Why?
|
Fimbriae, Bacterial | 4 | 2008 | 23 | 0.420 |
Why?
|
Bacterial Adhesion | 5 | 2018 | 37 | 0.420 |
Why?
|
Disease Models, Animal | 5 | 2018 | 1371 | 0.410 |
Why?
|
Rats, Inbred F344 | 5 | 2017 | 245 | 0.410 |
Why?
|
Naphthalimides | 1 | 2011 | 3 | 0.400 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2007 | 188 | 0.400 |
Why?
|
Intestinal Mucosa | 3 | 2011 | 122 | 0.400 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2011 | 20 | 0.390 |
Why?
|
Amino Acid Sequence | 9 | 2018 | 1180 | 0.390 |
Why?
|
Butyrates | 1 | 2011 | 31 | 0.390 |
Why?
|
Transcriptional Activation | 6 | 2007 | 172 | 0.390 |
Why?
|
Genetic Engineering | 2 | 2009 | 33 | 0.390 |
Why?
|
Quality of Life | 2 | 2017 | 481 | 0.390 |
Why?
|
Tryptophan | 1 | 2011 | 73 | 0.370 |
Why?
|
Protein Multimerization | 1 | 2011 | 103 | 0.360 |
Why?
|
Polysaccharides, Bacterial | 3 | 2010 | 12 | 0.350 |
Why?
|
Gene Deletion | 6 | 2018 | 166 | 0.350 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 95 | 0.340 |
Why?
|
Salmonella typhimurium | 7 | 2001 | 40 | 0.340 |
Why?
|
Signal Transduction | 7 | 2019 | 1908 | 0.330 |
Why?
|
Escherichia coli | 5 | 2021 | 453 | 0.320 |
Why?
|
Water Microbiology | 2 | 2014 | 76 | 0.320 |
Why?
|
Mutation | 14 | 2009 | 1095 | 0.320 |
Why?
|
Enhancer Elements, Genetic | 3 | 2005 | 62 | 0.310 |
Why?
|
Lipopolysaccharides | 6 | 2011 | 220 | 0.290 |
Why?
|
Alanine | 1 | 2007 | 30 | 0.290 |
Why?
|
Repressor Proteins | 1 | 2009 | 249 | 0.290 |
Why?
|
Models, Animal | 3 | 2017 | 134 | 0.290 |
Why?
|
Antibodies, Bacterial | 6 | 2014 | 109 | 0.280 |
Why?
|
Mice, Inbred C57BL | 11 | 2018 | 1609 | 0.280 |
Why?
|
Dipeptides | 1 | 2006 | 32 | 0.270 |
Why?
|
beta-Galactosidase | 4 | 2007 | 35 | 0.270 |
Why?
|
Peptides, Cyclic | 1 | 2006 | 29 | 0.270 |
Why?
|
Mast Cells | 3 | 2012 | 81 | 0.270 |
Why?
|
Protein Binding | 5 | 2014 | 972 | 0.270 |
Why?
|
Membrane Proteins | 1 | 2009 | 517 | 0.270 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2005 | 7 | 0.270 |
Why?
|
Immunoglobulin A, Secretory | 2 | 2018 | 16 | 0.260 |
Why?
|
Alkaline Phosphatase | 3 | 2012 | 50 | 0.250 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 109 | 0.250 |
Why?
|
Vibrio cholerae O139 | 1 | 2004 | 1 | 0.250 |
Why?
|
Amoeba | 1 | 2004 | 6 | 0.240 |
Why?
|
Toxins, Biological | 1 | 2024 | 3 | 0.240 |
Why?
|
Sodium | 1 | 2004 | 103 | 0.240 |
Why?
|
Intestine, Small | 2 | 2001 | 25 | 0.240 |
Why?
|
Oncorhynchus mykiss | 1 | 2023 | 2 | 0.230 |
Why?
|
Lung | 6 | 2010 | 446 | 0.230 |
Why?
|
Cell Aggregation | 1 | 2023 | 15 | 0.230 |
Why?
|
Amino Acid Substitution | 3 | 2011 | 132 | 0.230 |
Why?
|
Alleles | 2 | 2021 | 321 | 0.230 |
Why?
|
Mycobacterium marinum | 1 | 2003 | 7 | 0.230 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 306 | 0.230 |
Why?
|
Protein Structure, Tertiary | 5 | 2013 | 408 | 0.220 |
Why?
|
RNA Polymerase Sigma 54 | 5 | 2001 | 5 | 0.220 |
Why?
|
Mutation, Missense | 2 | 2014 | 83 | 0.210 |
Why?
|
Female | 20 | 2018 | 20969 | 0.210 |
Why?
|
Zebrafish | 1 | 2003 | 128 | 0.210 |
Why?
|
Models, Molecular | 5 | 2018 | 808 | 0.200 |
Why?
|
Interleukin-4 | 3 | 2012 | 72 | 0.200 |
Why?
|
Vibrio Infections | 2 | 2014 | 4 | 0.200 |
Why?
|
Chitin | 1 | 2021 | 19 | 0.200 |
Why?
|
Movement | 4 | 2004 | 97 | 0.190 |
Why?
|
Infant | 2 | 2023 | 1046 | 0.190 |
Why?
|
Gene Expression Regulation | 3 | 2012 | 1015 | 0.190 |
Why?
|
Host-Pathogen Interactions | 3 | 2012 | 186 | 0.190 |
Why?
|
Bacteria | 2 | 2023 | 255 | 0.190 |
Why?
|
Colony Count, Microbial | 4 | 2009 | 66 | 0.190 |
Why?
|
Antigens, Bacterial | 3 | 2009 | 132 | 0.190 |
Why?
|
Animals, Suckling | 3 | 2009 | 10 | 0.180 |
Why?
|
Temperature | 3 | 2014 | 286 | 0.180 |
Why?
|
Intracellular Membranes | 1 | 2000 | 38 | 0.180 |
Why?
|
Sequence Analysis, DNA | 3 | 2012 | 474 | 0.180 |
Why?
|
Cell Line | 6 | 2014 | 1354 | 0.180 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 626 | 0.170 |
Why?
|
Proteomics | 3 | 2007 | 325 | 0.170 |
Why?
|
Lipid A | 2 | 2011 | 7 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2012 | 259 | 0.160 |
Why?
|
Multigene Family | 3 | 2010 | 106 | 0.160 |
Why?
|
Immunologic Factors | 1 | 2018 | 45 | 0.160 |
Why?
|
Dermatitis, Atopic | 1 | 2018 | 12 | 0.160 |
Why?
|
Thioredoxins | 1 | 2018 | 42 | 0.160 |
Why?
|
Acinetobacter baumannii | 1 | 2018 | 33 | 0.160 |
Why?
|
Cytoskeleton | 1 | 2018 | 110 | 0.150 |
Why?
|
Glutamine | 2 | 2000 | 40 | 0.150 |
Why?
|
Lymphedema | 1 | 2017 | 8 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 3 | 2010 | 295 | 0.150 |
Why?
|
Protein Transport | 3 | 2012 | 302 | 0.150 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2007 | 269 | 0.150 |
Why?
|
Cost of Illness | 1 | 2017 | 76 | 0.150 |
Why?
|
Protein Conformation | 1 | 2018 | 389 | 0.150 |
Why?
|
Escherichia coli Proteins | 2 | 2012 | 126 | 0.140 |
Why?
|
Dimerization | 2 | 2007 | 112 | 0.140 |
Why?
|
Survival Analysis | 6 | 2018 | 325 | 0.130 |
Why?
|
Disease Susceptibility | 2 | 2010 | 97 | 0.130 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2005 | 53 | 0.130 |
Why?
|
Spleen | 6 | 2016 | 199 | 0.130 |
Why?
|
Glutamate-Ammonia Ligase | 3 | 2000 | 10 | 0.130 |
Why?
|
Immunization | 2 | 2012 | 92 | 0.130 |
Why?
|
Genes, Reporter | 2 | 2005 | 136 | 0.120 |
Why?
|
Macaca fascicularis | 1 | 2014 | 64 | 0.120 |
Why?
|
Toll-Like Receptor 5 | 1 | 2014 | 6 | 0.120 |
Why?
|
5' Untranslated Regions | 1 | 2014 | 18 | 0.120 |
Why?
|
Base Pairing | 1 | 2014 | 42 | 0.120 |
Why?
|
Models, Biological | 3 | 2007 | 677 | 0.120 |
Why?
|
Mutant Proteins | 1 | 2014 | 51 | 0.120 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 97 | 0.120 |
Why?
|
Sequence Alignment | 2 | 2008 | 265 | 0.120 |
Why?
|
Rats | 3 | 2017 | 3483 | 0.120 |
Why?
|
Protein Biosynthesis | 1 | 2014 | 133 | 0.120 |
Why?
|
Protein Interaction Mapping | 1 | 2014 | 61 | 0.120 |
Why?
|
Nucleic Acid Conformation | 1 | 2014 | 146 | 0.120 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2013 | 7 | 0.120 |
Why?
|
Binding Sites | 2 | 2005 | 651 | 0.110 |
Why?
|
Operon | 2 | 2007 | 44 | 0.110 |
Why?
|
Adenosine Triphosphate | 2 | 2012 | 196 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2011 | 149 | 0.110 |
Why?
|
Heme | 1 | 2013 | 70 | 0.110 |
Why?
|
Microbial Viability | 2 | 2009 | 37 | 0.110 |
Why?
|
Cells, Cultured | 7 | 2012 | 1518 | 0.110 |
Why?
|
Phosphorus-Oxygen Lyases | 1 | 2012 | 6 | 0.110 |
Why?
|
Hemerythrin | 1 | 2012 | 51 | 0.110 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2012 | 47 | 0.110 |
Why?
|
Cytoplasm | 2 | 2005 | 143 | 0.110 |
Why?
|
Bacteremia | 1 | 2012 | 30 | 0.110 |
Why?
|
Perforin | 1 | 2012 | 10 | 0.110 |
Why?
|
Open Reading Frames | 2 | 2010 | 77 | 0.110 |
Why?
|
Granzymes | 1 | 2012 | 16 | 0.100 |
Why?
|
Toll-Like Receptor 2 | 1 | 2012 | 27 | 0.100 |
Why?
|
DNA Transposable Elements | 2 | 2003 | 48 | 0.100 |
Why?
|
Gene Expression | 3 | 2008 | 674 | 0.100 |
Why?
|
Acyltransferases | 1 | 2011 | 21 | 0.100 |
Why?
|
Iron | 1 | 2013 | 225 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 3 | 2011 | 77 | 0.100 |
Why?
|
Mannose | 1 | 2011 | 25 | 0.100 |
Why?
|
Oligosaccharides | 1 | 2011 | 24 | 0.100 |
Why?
|
Early Growth Response Protein 1 | 1 | 2010 | 10 | 0.100 |
Why?
|
Cell Membrane | 2 | 2011 | 381 | 0.090 |
Why?
|
HLA-DR4 Antigen | 1 | 2009 | 20 | 0.090 |
Why?
|
Hemagglutination | 1 | 2009 | 3 | 0.090 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2009 | 10 | 0.090 |
Why?
|
Hemagglutinins | 1 | 2009 | 9 | 0.090 |
Why?
|
Phosphorylation | 4 | 2000 | 928 | 0.090 |
Why?
|
Transcription Initiation Site | 2 | 2009 | 14 | 0.090 |
Why?
|
Hemolysis | 1 | 2009 | 40 | 0.090 |
Why?
|
Recombinant Proteins | 3 | 2007 | 515 | 0.090 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2009 | 1 | 0.090 |
Why?
|
Vibrio cholerae non-O1 | 1 | 2009 | 2 | 0.080 |
Why?
|
Pseudomonas aeruginosa | 1 | 2009 | 57 | 0.080 |
Why?
|
Immunoglobulin A | 1 | 2009 | 58 | 0.080 |
Why?
|
NAD | 1 | 2009 | 50 | 0.080 |
Why?
|
Erythrocytes | 1 | 2009 | 111 | 0.080 |
Why?
|
Contact Inhibition | 1 | 2008 | 4 | 0.080 |
Why?
|
Acid Phosphatase | 1 | 2008 | 21 | 0.080 |
Why?
|
Gene Silencing | 1 | 2009 | 151 | 0.080 |
Why?
|
Cell Division | 2 | 2000 | 307 | 0.080 |
Why?
|
Spain | 1 | 2008 | 36 | 0.080 |
Why?
|
beta-Lactamases | 1 | 2008 | 33 | 0.080 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2008 | 110 | 0.080 |
Why?
|
Administration, Oral | 4 | 2012 | 224 | 0.080 |
Why?
|
Mice, Knockout | 4 | 2012 | 933 | 0.080 |
Why?
|
Isoelectric Focusing | 1 | 2007 | 15 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2007 | 25 | 0.080 |
Why?
|
Regulon | 1 | 2007 | 2 | 0.080 |
Why?
|
Kinetics | 4 | 2009 | 708 | 0.080 |
Why?
|
Administration, Intranasal | 4 | 2009 | 79 | 0.070 |
Why?
|
DNA Replication | 1 | 2008 | 152 | 0.070 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 78 | 0.070 |
Why?
|
PII Nitrogen Regulatory Proteins | 4 | 1994 | 4 | 0.070 |
Why?
|
Lac Operon | 1 | 2007 | 21 | 0.070 |
Why?
|
Cytosol | 1 | 2007 | 93 | 0.070 |
Why?
|
DNA Primers | 1 | 2007 | 286 | 0.070 |
Why?
|
Aspartic Acid | 2 | 2000 | 47 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2009 | 357 | 0.070 |
Why?
|
Mutagenesis | 1 | 2007 | 89 | 0.070 |
Why?
|
Culture Media, Conditioned | 1 | 2006 | 46 | 0.070 |
Why?
|
Environmental Microbiology | 3 | 2014 | 26 | 0.070 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2006 | 4 | 0.070 |
Why?
|
Gene Order | 2 | 2008 | 17 | 0.070 |
Why?
|
Gene Fusion | 1 | 2005 | 6 | 0.070 |
Why?
|
Luciferases | 1 | 2005 | 63 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 93 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2005 | 38 | 0.070 |
Why?
|
Cholera Vaccines | 2 | 2002 | 18 | 0.070 |
Why?
|
Artificial Gene Fusion | 1 | 2005 | 5 | 0.070 |
Why?
|
DNA Footprinting | 1 | 2005 | 9 | 0.070 |
Why?
|
Sepsis | 2 | 2018 | 80 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2006 | 123 | 0.060 |
Why?
|
Fluoroquinolones | 1 | 2005 | 7 | 0.060 |
Why?
|
Neutropenia | 1 | 2005 | 18 | 0.060 |
Why?
|
Phenotype | 2 | 2001 | 689 | 0.060 |
Why?
|
Interleukin-12 | 1 | 2004 | 47 | 0.060 |
Why?
|
Animals, Newborn | 2 | 2009 | 343 | 0.060 |
Why?
|
Escherichia coli Infections | 1 | 2005 | 41 | 0.060 |
Why?
|
Leukemia | 1 | 2005 | 56 | 0.060 |
Why?
|
Oxidation-Reduction | 2 | 2018 | 431 | 0.060 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 64 | 0.060 |
Why?
|
Fucose | 1 | 2024 | 4 | 0.060 |
Why?
|
Ampicillin Resistance | 1 | 2003 | 3 | 0.060 |
Why?
|
Recombinases | 1 | 2003 | 3 | 0.060 |
Why?
|
Host-Parasite Interactions | 1 | 2004 | 42 | 0.060 |
Why?
|
Adjuvants, Immunologic | 1 | 2004 | 107 | 0.060 |
Why?
|
Bioterrorism | 1 | 2003 | 20 | 0.060 |
Why?
|
Blotting, Western | 2 | 2008 | 859 | 0.060 |
Why?
|
Basal Metabolism | 1 | 2023 | 6 | 0.060 |
Why?
|
Acclimatization | 1 | 2023 | 21 | 0.060 |
Why?
|
Polysaccharides | 1 | 2024 | 58 | 0.060 |
Why?
|
Climate Change | 1 | 2023 | 35 | 0.060 |
Why?
|
Mammals | 1 | 2024 | 105 | 0.060 |
Why?
|
Bacterial Capsules | 1 | 2002 | 6 | 0.050 |
Why?
|
Vaccines | 1 | 2003 | 55 | 0.050 |
Why?
|
Ion Channels | 1 | 2003 | 71 | 0.050 |
Why?
|
Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2001 | 3 | 0.050 |
Why?
|
Yersinia pseudotuberculosis | 1 | 2001 | 7 | 0.050 |
Why?
|
Polymyxin B | 2 | 2011 | 8 | 0.050 |
Why?
|
Detergents | 1 | 2001 | 24 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2001 | 116 | 0.050 |
Why?
|
Chemotactic Factors | 1 | 2001 | 7 | 0.050 |
Why?
|
UDPglucose 4-Epimerase | 1 | 2001 | 1 | 0.050 |
Why?
|
UTP-Glucose-1-Phosphate Uridylyltransferase | 1 | 2001 | 12 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2001 | 87 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2002 | 155 | 0.050 |
Why?
|
Chemotaxis | 1 | 2001 | 60 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2000 | 21 | 0.050 |
Why?
|
Genes, MHC Class I | 2 | 2012 | 13 | 0.050 |
Why?
|
Enterotoxins | 1 | 2000 | 33 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2012 | 444 | 0.050 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 20 | 0.050 |
Why?
|
Cell Death | 2 | 2012 | 267 | 0.050 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2000 | 21 | 0.050 |
Why?
|
Hemolysin Proteins | 1 | 2000 | 4 | 0.050 |
Why?
|
Bacteriophages | 1 | 2000 | 44 | 0.050 |
Why?
|
Photobacterium | 1 | 2000 | 5 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2000 | 35 | 0.040 |
Why?
|
Phosphates | 1 | 2000 | 51 | 0.040 |
Why?
|
Middle Aged | 5 | 2018 | 10129 | 0.040 |
Why?
|
Species Specificity | 2 | 2012 | 245 | 0.040 |
Why?
|
Anti-Bacterial Agents | 3 | 2011 | 352 | 0.040 |
Why?
|
Lymphocyte Depletion | 2 | 2009 | 13 | 0.040 |
Why?
|
Adult | 5 | 2018 | 11712 | 0.040 |
Why?
|
Genes, Regulator | 1 | 1998 | 25 | 0.040 |
Why?
|
Symbiosis | 2 | 2010 | 43 | 0.040 |
Why?
|
Software | 1 | 2000 | 217 | 0.040 |
Why?
|
Pressure | 1 | 2018 | 43 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1998 | 90 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 1998 | 209 | 0.040 |
Why?
|
Germany | 1 | 2017 | 24 | 0.040 |
Why?
|
Inservice Training | 1 | 2018 | 33 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 2 | 2009 | 234 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 1998 | 188 | 0.040 |
Why?
|
O Antigens | 2 | 2011 | 5 | 0.040 |
Why?
|
Adoptive Transfer | 2 | 2008 | 48 | 0.040 |
Why?
|
Gene Transfer, Horizontal | 2 | 2010 | 24 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2008 | 189 | 0.040 |
Why?
|
Genome, Bacterial | 2 | 2009 | 114 | 0.040 |
Why?
|
Aged | 4 | 2017 | 6741 | 0.040 |
Why?
|
Genetic Complementation Test | 2 | 2011 | 59 | 0.040 |
Why?
|
Mass Spectrometry | 2 | 2011 | 260 | 0.040 |
Why?
|
Phylogeny | 1 | 2000 | 644 | 0.030 |
Why?
|
Biological Transport | 1 | 1997 | 185 | 0.030 |
Why?
|
Computational Biology | 2 | 2009 | 293 | 0.030 |
Why?
|
HT29 Cells | 2 | 2006 | 45 | 0.030 |
Why?
|
Nitrogen | 1 | 1997 | 71 | 0.030 |
Why?
|
Protein Structure, Secondary | 2 | 1993 | 183 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2016 | 53 | 0.030 |
Why?
|
Immunity | 1 | 2016 | 53 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2016 | 89 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 1994 | 25 | 0.030 |
Why?
|
Liver | 2 | 2008 | 479 | 0.030 |
Why?
|
Ureteral Calculi | 1 | 1974 | 3 | 0.030 |
Why?
|
Incidence | 2 | 2009 | 922 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2018 | 1369 | 0.030 |
Why?
|
Eubacterium | 1 | 1993 | 1 | 0.030 |
Why?
|
Glutamates | 1 | 1993 | 22 | 0.030 |
Why?
|
Male | 4 | 2018 | 20025 | 0.030 |
Why?
|
Polymers | 1 | 1994 | 121 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 52 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2013 | 109 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 2 | 2005 | 201 | 0.030 |
Why?
|
Ligands | 1 | 2014 | 349 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2012 | 13 | 0.030 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 2012 | 8 | 0.030 |
Why?
|
Chaperonin 60 | 1 | 2012 | 18 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2012 | 98 | 0.030 |
Why?
|
Immunity, Mucosal | 1 | 2012 | 47 | 0.030 |
Why?
|
Molecular Weight | 1 | 2012 | 167 | 0.030 |
Why?
|
Carrier Proteins | 1 | 1994 | 305 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2012 | 47 | 0.030 |
Why?
|
Phosphoproteins | 1 | 1993 | 163 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 1993 | 409 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2012 | 101 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 62 | 0.030 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 132 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 1991 | 82 | 0.020 |
Why?
|
Nitrites | 1 | 2011 | 46 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 159 | 0.020 |
Why?
|
Receptors, Interleukin-4 | 1 | 2010 | 10 | 0.020 |
Why?
|
Milk | 1 | 2011 | 50 | 0.020 |
Why?
|
Mannose-Binding Lectins | 1 | 2010 | 14 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2009 | 2379 | 0.020 |
Why?
|
Organelles | 1 | 2010 | 24 | 0.020 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 34 | 0.020 |
Why?
|
Brazil | 1 | 2010 | 64 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 2010 | 36 | 0.020 |
Why?
|
Gentamicins | 2 | 2004 | 10 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2012 | 308 | 0.020 |
Why?
|
Oligopeptides | 1 | 2010 | 102 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 2721 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 144 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 207 | 0.020 |
Why?
|
Mice, SCID | 1 | 2009 | 150 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 176 | 0.020 |
Why?
|
IgA Deficiency | 1 | 2009 | 6 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2009 | 64 | 0.020 |
Why?
|
Bacillus anthracis | 1 | 2009 | 33 | 0.020 |
Why?
|
India | 1 | 2009 | 88 | 0.020 |
Why?
|
Endosomes | 1 | 2008 | 36 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2010 | 268 | 0.020 |
Why?
|
Intracellular Space | 1 | 2008 | 35 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 433 | 0.020 |
Why?
|
Diarrhea | 1 | 2009 | 89 | 0.020 |
Why?
|
Receptors, IgG | 1 | 2008 | 50 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 146 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2008 | 70 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 623 | 0.020 |
Why?
|
Silver Staining | 1 | 2007 | 7 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2009 | 617 | 0.020 |
Why?
|
Superinfection | 1 | 2007 | 2 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2008 | 212 | 0.020 |
Why?
|
Survival Rate | 1 | 2008 | 311 | 0.020 |
Why?
|
Organisms, Genetically Modified | 1 | 2006 | 5 | 0.020 |
Why?
|
Body Weight | 1 | 2009 | 434 | 0.020 |
Why?
|
Computer Simulation | 1 | 2009 | 362 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 448 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2006 | 60 | 0.020 |
Why?
|
Pneumonia, Bacterial | 1 | 2006 | 22 | 0.020 |
Why?
|
Proteome | 1 | 2007 | 144 | 0.020 |
Why?
|
Adolescent | 2 | 2009 | 5363 | 0.020 |
Why?
|
Th1 Cells | 1 | 2006 | 92 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2009 | 894 | 0.020 |
Why?
|
Biodiversity | 1 | 2006 | 83 | 0.020 |
Why?
|
Cathepsin D | 1 | 2005 | 17 | 0.020 |
Why?
|
Macrophage Activation | 1 | 2005 | 56 | 0.020 |
Why?
|
Hospitalization | 1 | 2009 | 388 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2005 | 7 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2005 | 17 | 0.020 |
Why?
|
Antigens, CD | 1 | 2005 | 121 | 0.020 |
Why?
|
Base Composition | 1 | 2004 | 23 | 0.020 |
Why?
|
Lysosomes | 1 | 2005 | 91 | 0.020 |
Why?
|
Phagocytosis | 1 | 2004 | 69 | 0.020 |
Why?
|
Child, Preschool | 1 | 2009 | 1418 | 0.020 |
Why?
|
Acanthamoeba | 1 | 2003 | 5 | 0.010 |
Why?
|
Pseudomonas Infections | 1 | 2003 | 18 | 0.010 |
Why?
|
Ion Transport | 1 | 2003 | 17 | 0.010 |
Why?
|
Electrophysiology | 1 | 2003 | 136 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 1207 | 0.010 |
Why?
|
Cephaloridine | 1 | 2002 | 1 | 0.010 |
Why?
|
Yersinia pseudotuberculosis Infections | 1 | 2001 | 3 | 0.010 |
Why?
|
Galactose | 1 | 2001 | 8 | 0.010 |
Why?
|
Serotyping | 1 | 2000 | 36 | 0.010 |
Why?
|
Chromosomes, Bacterial | 1 | 2000 | 20 | 0.010 |
Why?
|
Child | 1 | 2009 | 3131 | 0.010 |
Why?
|
Adsorption | 1 | 2000 | 68 | 0.010 |
Why?
|
Germ-Free Life | 1 | 2000 | 3 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2001 | 218 | 0.010 |
Why?
|
Entamoeba histolytica | 1 | 2000 | 4 | 0.010 |
Why?
|
Antigens, Protozoan | 1 | 2000 | 72 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 4268 | 0.010 |
Why?
|
Carbenicillin | 1 | 1974 | 1 | 0.010 |
Why?
|
Nephrectomy | 1 | 1974 | 23 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1974 | 35 | 0.010 |
Why?
|
Fever | 1 | 1974 | 57 | 0.010 |
Why?
|
Prokaryotic Cells | 1 | 1993 | 9 | 0.010 |
Why?
|
Eukaryotic Cells | 1 | 1993 | 36 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1974 | 227 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1991 | 25 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1991 | 67 | 0.010 |
Why?
|